Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.02 -0.02 (-1.92%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) Operating Leases (2022 - 2023)

Updated

Cadrenal Therapeutics (CVKD) reported Operating Leases of $2,232 for Q3 2023, down 74.6% from the prior quarter.

Analysis

Cadrenal Therapeutics (CVKD) Operating Leases (2022 - 2023) Analysis & Trends

At the end of FY2022, Cadrenal Therapeutics posted Operating Leases of $21,350.

  • Per Business Quant data, the three quarters before Q3 2023 came in at $8,796 (Q2 2023), $15,167 (Q1 2023) and $21,350 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Cadrenal Therapeutics 2.95 Mn -9.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 2,232.00
Jun 30, 2023 8,796.00
Mar 31, 2023 15,167.00
Dec 31, 2022 21,350.00
API Access

Cadrenal Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=CVKD&period=max&api_key=YOUR_API_KEY